Is MEDIFAST INC Stock a Good Investment?
MEDIFAST INC Investment Advice | MED |
- Examine MEDIFAST INC's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research MEDIFAST INC's leadership team and their track record. Good management can help MEDIFAST INC navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Personal Care Products space and any emerging trends that could impact MEDIFAST INC's business and its evolving consumer preferences.
- Compare MEDIFAST INC's performance and market position to its competitors. Analyze how MEDIFAST INC is positioned in terms of product offerings, innovation, and market share.
- Check if MEDIFAST INC pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about MEDIFAST INC's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in MEDIFAST INC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if MEDIFAST INC is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine MEDIFAST INC Stock
Researching MEDIFAST INC's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 86.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDIFAST INC has Price/Earnings To Growth (PEG) ratio of 1.95. The entity last dividend was issued on the 18th of September 2023. The firm had 1:20 split on the February 14, 2011.
To determine if MEDIFAST INC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding MEDIFAST INC's research are outlined below:
| MEDIFAST INC generated a negative expected return over the last 90 days | |
| MEDIFAST INC is unlikely to experience financial distress in the next 2 years | |
| Over 86.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Plant-based Beverage Market is Estimated to Reach 56.73 Billion with a 11.9 percent CAGR By 2034 Fact.MR Reports |
MEDIFAST INC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in MEDIFAST INC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MEDIFAST INC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact MEDIFAST INC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises MEDIFAST INC's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2009-03-12 | 2008-12-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2007-11-08 | 2007-09-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2005-11-09 | 2005-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2005-05-10 | 2005-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2005-03-14 | 2004-12-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2004-08-16 | 2004-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2004-03-15 | 2003-12-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2010-03-04 | 2009-12-31 | 0.19 | 0.21 | 0.02 | 10 |
Know MEDIFAST INC's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MEDIFAST INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEDIFAST INC backward and forwards among themselves. MEDIFAST INC's institutional investor refers to the entity that pools money to purchase MEDIFAST INC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jane Street Group Llc | 2024-06-30 | 262.9 K | Man Group Plc | 2024-06-30 | 241.8 K | American Century Companies Inc | 2024-09-30 | 236.1 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 232.9 K | State Street Corp | 2024-06-30 | 228.5 K | Federated Hermes Inc | 2024-09-30 | 216.9 K | Susquehanna International Group, Llp | 2024-06-30 | 215.3 K | Two Sigma Investments Llc | 2024-06-30 | 191.4 K | Qube Research & Technologies | 2024-06-30 | 177.2 K | Renaissance Technologies Corp | 2024-09-30 | 1 M | Blackrock Inc | 2024-06-30 | 829.2 K |
MEDIFAST INC's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 198.63 M.Market Cap |
|
MEDIFAST INC's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.32 | 0.34 | |
| Return On Capital Employed | 0.58 | 0.61 | |
| Return On Assets | 0.32 | 0.34 | |
| Return On Equity | 0.49 | 0.84 |
Determining MEDIFAST INC's profitability involves analyzing its financial statements and using various financial metrics to determine if MEDIFAST INC is a good buy. For example, gross profit margin measures MEDIFAST INC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of MEDIFAST INC's profitability and make more informed investment decisions.
Please note, the presentation of MEDIFAST INC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEDIFAST INC's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MEDIFAST INC's management manipulating its earnings.
Evaluate MEDIFAST INC's management efficiency
MEDIFAST INC has Return on Asset of 0.0477 % which means that on every $100 spent on assets, it made $0.0477 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0366 %, implying that it generated $0.0366 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.34. The current year's Return On Capital Employed is expected to grow to 0.61. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 15.4 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 2.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 18.51 | 19.44 | |
| Tangible Book Value Per Share | 18.51 | 19.44 | |
| Enterprise Value Over EBITDA | 4.73 | 6.96 | |
| Price Book Value Ratio | 3.63 | 4.14 | |
| Enterprise Value Multiple | 4.73 | 6.96 | |
| Price Fair Value | 3.63 | 4.14 | |
| Enterprise Value | 397.2 M | 417.1 M |
MEDIFAST INC benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Beta 1.158 |
Basic technical analysis of MEDIFAST Stock
As of the 22nd of November, MEDIFAST INC secures the risk adjusted performance of (0.01), and Mean Deviation of 2.09. Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MEDIFAST INC, as well as the relationship between them. Please verify MEDIFAST INC variance, as well as the relationship between the maximum drawdown and skewness to decide if MEDIFAST INC is priced fairly, providing market reflects its recent price of 18.3 per share. Given that MEDIFAST INC has information ratio of (0.06), we recommend you to check MEDIFAST INC's last-minute market performance to make sure the company can sustain itself in the future.MEDIFAST INC's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MEDIFAST INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on MEDIFAST INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MEDIFAST INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MEDIFAST INC's Outstanding Corporate Bonds
MEDIFAST INC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MEDIFAST INC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MEDIFAST bonds can be classified according to their maturity, which is the date when MEDIFAST INC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand MEDIFAST INC's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing MEDIFAST INC's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 2.09 | |||
| Coefficient Of Variation | (4,096) | |||
| Standard Deviation | 2.7 | |||
| Variance | 7.29 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 15.04 | |||
| Value At Risk | (3.72) | |||
| Potential Upside | 4.85 | |||
| Skewness | 0.4414 | |||
| Kurtosis | 0.7643 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 2.09 | |||
| Coefficient Of Variation | (4,096) | |||
| Standard Deviation | 2.7 | |||
| Variance | 7.29 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 15.04 | |||
| Value At Risk | (3.72) | |||
| Potential Upside | 4.85 | |||
| Skewness | 0.4414 | |||
| Kurtosis | 0.7643 |
Consider MEDIFAST INC's intraday indicators
MEDIFAST INC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MEDIFAST INC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 8947.68 | |||
| Daily Balance Of Power | 0.2258 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 18.37 | |||
| Day Typical Price | 18.35 | |||
| Period Momentum Indicator | 0.14 | |||
| Relative Strength Index | 62.21 |
MEDIFAST INC Corporate Filings
| 13th of November 2024 Other Reports | ViewVerify | |
8K | 4th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 31st of October 2024 Other Reports | ViewVerify | |
F4 | 17th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
MEDIFAST Stock media impact
Far too much social signal, news, headlines, and media speculation about MEDIFAST INC that are available to investors today. That information is available publicly through MEDIFAST media outlets and privately through word of mouth or via MEDIFAST internal channels. However, regardless of the origin, that massive amount of MEDIFAST data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MEDIFAST INC news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MEDIFAST INC relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MEDIFAST INC's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MEDIFAST INC alpha.
MEDIFAST INC Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards MEDIFAST INC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MEDIFAST INC Corporate Directors
| Ming Xian | Independent Director | Profile | |
| Michael Hoer | Independent Director | Profile | |
| Jeffrey Brown | Lead Independent Director | Profile | |
| Scott Schlackman | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share 0.67 | Revenue Per Share 61.769 | Quarterly Revenue Growth (0.41) | Return On Assets 0.0477 |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between MEDIFAST INC's value and its price, as these two are different measures arrived at by various means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.